Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

61
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
61
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

59
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
59
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

35
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
35
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

263
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis?

Infection·2026
Same author

Wherefore the Magic? The Evolutionary Role of Psilocybin in Nature.

Ecology and evolution·2026
Same author

Cerebral toxoplasmosis in the twenty-first century.

AIDS (London, England)·2025
Same author

Increased number of positive coagulase-negative staphylococci in blood cultures is partly explained by increased use of intra-arterial catheters in patients with COVID-19.

The Journal of hospital infection·2021
Same author

How practice nurses engage with parents during their consultations about the MMR vaccine: a qualitative study.

Primary health care research & development·2021
Same author

Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study.

EClinicalMedicine·2021

Related Experiment Video

Updated: Apr 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K

Current knowledge and future perspectives on acute hepatitis C infection.

S J Hullegie1, J E Arends2, B J A Rijnders1

  • 1Department of Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|April 21, 2015
PubMed
Summary

Acute hepatitis C virus (HCV) infection diagnosis is often delayed due to asymptomatic acute phases. This review covers current knowledge and future directions for HCV epidemiology, immunology, and treatment.

Keywords:
Acute hepatitis Cepidemiologyimmunologytreatmentvirology

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Related Experiment Videos

Last Updated: Apr 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Acute hepatitis C virus (HCV) infections present a global health challenge with significant incidence rates in specific populations.
  • Diagnosis is often delayed as the acute phase is typically asymptomatic, leading to detection during chronic infection.
  • Current diagnostic methods like antibody seroconversion and HCV RNA monitoring lack definitive accuracy for acute cases.

Purpose of the Study:

  • To provide a comprehensive overview of the current understanding of acute hepatitis C.
  • To highlight existing knowledge gaps and future research directions.
  • To discuss advancements in HCV vaccine development and viral persistence.

Main Methods:

  • Review of current literature on acute hepatitis C epidemiology, virology, and immunology.
  • Analysis of diagnostic challenges and limitations.
  • Exploration of evolving treatment strategies and their impact on acute HCV management.

Main Results:

  • Acute HCV infection incidence varies widely (0.08%-66%) globally.
  • No definitive diagnostic test for acute HCV infection is currently available.
  • Progress in understanding immune responses aids vaccine development and comprehension of viral persistence.

Conclusions:

  • Advances in immunology and virology are crucial for improving acute HCV diagnosis and treatment.
  • Future therapeutic regimens for acute HCV will likely involve shorter, interferon-free treatments.
  • Further research is needed to address diagnostic uncertainties and optimize management strategies for acute hepatitis C.